Body Fat Distribution and Plasma Lipid Profiles of Patients with Multiple Sclerosis

Turkish Journal of Medical Sciences

Volumn 34, Issue 1, 2004, Pages 43-48

  Çomoǧlu, Selçuk ^a,d   Yardimci, Serdar ^b   Okçu, Zeki ^c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Ankara Rehabilitation Center   (Turkey)

^d Birlik Mahallesi   (Turkey)

Author keywords

Body composition; Body mass index; Lipid metabolism; Multiple sclerosis

Indexed keywords

CHOLESTEROL; DIAGNOSIS; HEALTH; LIPIDS; METABOLISM; OILS AND FATS; PATIENT MONITORING; PLASMAS;

BODY FAT DISTRIBUTION; PLASMA LIPIDS;

BIOMEDICAL ENGINEERING;

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY REGIONS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MULTIPLE SCLEROSIS; SKINFOLD; SPECTROPHOTOMETRY; SUBCUTANEOUS FAT; TRUNK;

EID: 1542285912     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Esparza MI, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol; 142: 733-737, 1995.
2. Formica CA, Cosman F, Nievers J et al. Reduced bone mass and fat-free mass in women with multiple sclerosis: Effects of ambulatory status and glucocorticod use. Calcif Tissue Int 61: 129-133, 1997.
3. Sayetta RB. Theories of the etiology of multiple sclerosis: A critical review. J Clin Lab Immunol 21: 55-70, 1986.
4. Petejan JH, Gappmaier E, White AT et al. Impact of aerobic training of fitness and quality of life in multiple sclerosis. Ann Neurol 39: 432-441, 1996.
5. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336: 37-39, 1990.
6. Swank RL, Grimgard A. Multiple sclerosis: the lipid relationship. Am J Clin Nutr 48: 1387-1393, 1998.
7. Swank RL. Multiple sclerosis: Fat-oil relationship. Nutrition 7: 368-376, 1991.
8. Cunnane SC, Ho SY, Dore-Duffy P et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr 50: 801-806, 1989.
9. A, Minghetti L, Sette G et al. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53: 1876-1879, 1999.
10. Cheragil GD. Effects of in vitro hyperthermia on fatty acids of red blood cells and plasma lipids from patients with multiple sclerosis. J Neurol Sci 95: 141-151, 1990.
11. Sugera XNR. Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurol Scand 78: 152-157, 1988.
12. Newcombe J, Lihe D, Cuzner ML. Low density lipoprotein uptake by macrophage in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20: 152-162, 1994.
13. Nue IS, Prosiegel M, Pfafenrath V. Platelet aggregation and multiple sclerosis. Acta Neurol Scand 66: 497-504, 1982.
14. Nue IS. Essential fatty adds in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol Scand 7: 151-163, 1983.
15. Ben-Shlomo Y, Davey Smith G, Marmot MG. Dietary fat in the epidemiology of multiple sclerosis: has the stimulation been adequately assessed. Neuroepidemiology 11: 214-225, 1992.
16. Navarro X, Segura R. Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurol Scand 78: 152-157, 1988.
17. Nanji AA, Narod S. Multiple sclerosis, latitude and dietary fat: is pork the missing link? Med Hypotheses 20: 279-282, 1986.
18. Fernandez O. Multiple sclerosis and a fat-poor diet. Neurologia 6: 235-237, 1991.
19. Alberts JJ, Marcovina SM, Christensen RH. Lecithin cholesterol acyltransferase in human cerebrospinal fluid: Reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain. Int J Clin Lab Res 22: 169-172, 1992.
20. Baker RWR, Thompson RHS, Zilkha KJ. Fatty acid composition of brain lecithins in multiple sclerosis. Lancet 1: 26-27, 1963.
21. Mc Neil G, Fowler PA, Maughan RJ et al. Body fat in lean and overweight women estimated by six methods. British Journal of Nutrition 65: 95-103, 1991.
22. Mueller WH, Wear MI, Hanis CL et al. Which measure of body fat distribution is best for epidemiologic research? American Journal of Epidemiologia 133: 858-869, 1991.
23. Swank RI, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336: 37-39, 1990.
24. Navarro X, Segura R. Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurologica Scandinavia 1988; 78: 152-157. 1998.
25. Cunnane SC, Hoe SY, Dore-Duffy P et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. American Journal of Clinical Nutrition 50: 801-806, 1989.
26. Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R. Reduced bone mass and fat-free mass in women with multiple sclerosis: Effects of ambulatory status and glucocorticoid use. Calcified Tissue Int 61: 129-133, 1997.
27. Roubenoff R, Rall LC. Humoral mediation of changing body composition during aging and chronic inflammation. Nutrition Reviews 51: 1-11, 1993.
28. Maghraoui AE, Borderie D, Cherruau B et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26: 2205-2209, 1999.
29. Freedman DS, Jacobsen SJ, Barboriak JJ et al. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 81: 1498-1506, 1990.
30. Westhovens R, Wijs J, Taelman V et al. Body composition in rheumatoid arthritis. Br J Rheumatol 36: 444-448, 1997.
31. Kent-Braun JA, Castro M, Weiner MW et al. Strength, skeletal muscle composition, and enzyme activities in multiple sclerosis. Journal Applied of Physiology 83: 1998-2004, 1997.
32. Greco A, Minghetti L, Sette G et al. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53: 1876-1879, 1999.
33. Svenningsson A, Petersson AS, Andersen O et al. Nitric oxide metabolisms in CSF of patients with MS are related to clinical disease course. Neurology 53: 1880-1882, 1999.
34. Petejan JH, Gappmaier E, White AT et al. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Annual Neurology 39: 432-441, 1996.
35. Durning VGA, Womersly J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. British Journal of Nutrition 32: 77-97, 1974.
36. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. British Journal of Nutrition 65: 105-114. 1991.
37. Gray DS, Bray GA, Bauer M et al. Skinfold thickness measurements in obese subjects. American Journal of Clinical Nutrition 51: 571-577, 1990.
38. Hergenroeder AC, Klish WJ. Body composition in adolescent athletes. Pediatric Clinic North America 37: 1057-1083, 1990.
39. Lohman TG. Skinfolds and body density and their relation to body fatness: A review. Human Biologia 53: 181-225, 1981.
40. Verlooy H, Dequeker J, Geusens P et al. Body composition by intercomparison of underwater weighing, skinfold measurements and dual-photon absorptiometry. British Journal Radiology 64: 765-767, 1991.
41. Hollman RT, Johnson SB, Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 86: 4720-4724, 1989.
42. Sandyk R, Awerbuch GI. The relationship between melatonin secretion and serum cholesterol in patients with multiple sclerosis. Int J Neurosci 76: 81-86, 1994.
43. De Andres C, Liedo A. Fatty diet and multiple sclerosis. Rev Neurol 25: 2032-2035, 1997.
44. Allen IV. The pathology of multiple sclerosis, fact-fiction and hypothesis. Neuropathol Appl Neurobiol 7: 169-182, 1981.
45. Adams CW, Poston RN. Macrophage histology in paraffin-embedded multiple sclerosis plaques in demonstrated by the monoclonal pan-macrophage marker HAM-56: Correlation with chronicity of the lesion. Acta Neuropathol 80: 208-211, 1990.
46. Osman I, Gaillard O, Meillet D et al. A sensitive time-resolved immunfluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Eur J Clin Chem Clin Biochem 33: 53-58, 1995.
47. Sepcic J, Mesaros E, Materjan E et al. Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neuroepidemiology 12: 234-240, 1993.
48. Steen G, Axellson H, Bowallius M et al. Isoprenoid biosynthesis in multiple sclerosis, II. A possible role of NADPH. Acta Neurol Scand 76: 461-467, 1987.
49. Uhlig H, Dernick R. Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system. Autoimmunity 5: 87-89, 1989.